SARS-CoV-2 Spike RBD (receptor binding domain), 336-347

This peptide sequence represents residues 336-347 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2.

Online Inquiry

CAT#S29009
SequenceOne Letter Code: CPFGEVFNATRF
Three-Letter Code: H-Cys-Pro-Phe-Gly-Glu-Val-Phe-Asn-Ala-Thr-Arg-Phe-OH
Purity95%
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

 Somatostatin is the main hemostatic drug in the clinic, and its derivative octreotide has been confirmed by many ...

 Acetyl pepstatin, nature products of yeast fermentation, is general inhibitors of the family of aspartic proteas ...

The mammalian precursor gene proglucagon, which contains the glucagon sequence together with two structurally related glucago ...

 As a small actin-binding protein upregulated in highly metastatic prostate cancer cells, thymosin β15 (Tβ15) has ...

 Tetracosactide (also known as Tetracosactide) is a synthetic peptide that is identical to the 24-amino acid segm ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.